Acne consultation

The consultation covers active acne management across teenage and adult presentations, hormonal-axis-driven adult acne in women, post-acne marks (post-inflammatory hyperpigmentation), and acne-scar pathway assessment. The framework distinguishes active acne from post-acne marks from acne scars because each requires a different management framework. Severe, painful, or scarring presentations are routed for prompt dermatologist assessment rather than for self-managed pathways.

Active acne is the inflammatory and non-inflammatory lesions present on the skin currently — comedones, papules, pustules, nodules, cysts. Post-acne marks are the dark or red patches that remain after a lesion resolves and represent post-inflammatory pigment or vascular response rather than scarring; these typically fade across months. Acne scars are the textural changes (atrophic, rolling, boxcar, ice-pick, or selected hypertrophic patterns) that represent permanent collagen disruption and need their own pathway. Many patients have all three concurrently.

Yes. Early intervention often reduces total scar burden and shortens the active-management window. The framework welcomes mild-acne consultations and does not require the patient to have already failed multiple over-the-counter pathways before seeking dermatologist input. Treating early often produces calibrated outcomes faster than treating later.

Severe presentations that warrant prompt dermatologist assessment include painful nodulocystic acne, rapidly worsening acne with scar-formation in progress, acne fulminans presentations, severe hormonal-axis-driven flares, and acne associated with selected systemic-context overlays. The framework does not delay these cases through prolonged self-management; the consultation framework is calibrated to handle severe presentations promptly with appropriate medical-pathway escalation.

No, the framework operates the same dermatology consultation for both, with sex-specific calibration where it matters. Adult women have a higher hormonal-axis component requiring relevant blood-work consideration in selected cases; adult men with persistent severe acne similarly receive appropriate calibration. The framework does not channel female patients toward cosmetic packages and male patients toward medical pathways — the calibration follows the case rather than demographic-segmentation.

Examination assesses lesion type and distribution across the face, neck, shoulders, chest, and back where relevant; severity grading using established dermatology grading frameworks; scar architecture assessment where scarring is present; and selected dermoscopy where the differential warrants it. The framework treats grading as substantive rather than as a scripted display, because it shapes the recommendation directly.

History covers the timeline and trajectory of the acne, prior treatment responses, current and prior topical and oral pathways tried, family pattern, hormonal-axis context (menstrual-cycle pattern, post-partum context, contraceptive context, PCOS context for women), occupational and lifestyle context, current skincare regime, and current diet and stress context where relevant. Many adult-acne presentations are calibrated by the cumulative interaction of these factors.

For pathways with structured progress monitoring — particularly active acne management with multi-month timelines and scar-resurfacing pathways — a calibrated photographic baseline is established with patient consent. Default use is clinical-record-only. Photographic-tracking framework detail sits at the medical photography page. Patients who prefer not to be photographed are accommodated within the limits of accurate progress assessment.

For selected adult-acne presentations particularly in women, blood-work investigation into hormonal-axis context (PCOS-relevant panel, thyroid-axis, selected hormonal contexts) is appropriate. Blood-work is requested where it shifts the recommendation, not as a default panel applied to every visit. Where the picture suggests systemic-context relevance the framework collaborates with internal medicine, gynaecology, or endocrinology.

Skincare review is substantive in acne pathways. Selected over-the-counter "anti-acne" products contain ingredients that disrupt the barrier or trigger PIH-prone responses; selected products mismatched to the patient\'s skin context can worsen the trajectory. The consultation reviews the regime and discusses whether elements need to be paused, replaced, or supplemented rather than upselling clinic-branded products.

Mild-to-moderate acne management is structured around the medical-dermatology framework — calibrated topical pharmacology (selected ingredient combinations from the standard dermatology toolkit), supportive skincare regime adjustments, and structured follow-up across the active management window. Procedural adjuncts (calibrated chemical peel pathways for selected cases, selected light-based pathways) act as supports rather than substitutes for the medical foundation.

Oral pharmacology becomes part of the framework for moderate-to-severe presentations, hormonal-axis-driven adult female acne, scar-prevention contexts where active management has not controlled the trajectory, and selected nodulocystic presentations. Oral pathways are calibrated within the standard MD-Dermatology toolkit alongside relevant blood-work review and informed-consent conversation covering the expected experience and residual-risk profile.

Adult female acne with hormonal-axis component (jawline-and-chin distribution, premenstrual flare pattern, PCOS-related context) calibrates pathway selection toward the hormonal-axis consideration. Topical and oral pharmacology, hormonal-axis investigation through appropriate blood-work, collaboration with gynaecology where the case warrants it, and lifestyle-context support together form the framework. The recommendation arrives at the consultation through that conversation rather than as a single-product promise.

Post-acne marks (post-inflammatory pigmentation) management starts with controlling the underlying acne so new marks stop forming, then supports the natural fade trajectory through calibrated topical actives and daily photoprotection. Selected calibrated chemical peel pathways and selected calibrated laser pathways support the timeline in some cases; the framework states honestly that PIH typically resolves over months rather than weeks. The pigmentation consultation page covers the broader pigmentation framework.

Acne scar management is a separate pathway from active acne management. Scar architecture (ice-pick, rolling, boxcar, atrophic, hypertrophic, keloid) shapes the recommendation. Calibrated procedural pathways — fractional CO2 laser, microneedling-RF, subcision for selected rolling-scar presentations, TCA cross for selected ice-pick presentations, calibrated chemical peel pathways — act as the toolkit. Multi-session multi-modality approaches are typical, and the framework calibrates the realistic outcome honestly rather than promising scar-free skin. The acne and scars page covers the framework in detail.

The plan covers the calibrated recommendation for active acne management, the rationale, the realistic outcome trajectory across an evidence-based timeline (typically months for active management; longer for scar-resurfacing), the maintenance pattern, the residual-risk profile, the per-component pricing for the recommended pathway, the supporting skincare regime, the proposed follow-up cadence, and any blood-work or referral routing. The plan is patient-side at the close of the visit; the proceed-decision is the patient's.

For active acne the realistic trajectory is typically a meaningful reduction in active lesions across two-to-three months of calibrated management, with continued improvement and selected maintenance into the longer-term window. For scar-resurfacing the realistic outcome is a calibrated improvement on the treated zone against the baseline rather than a complete reset to scar-free skin; multi-session multi-modality courses move the trajectory but do not erase the architectural change. The framework states this honestly rather than promising rapid full clearance.

Residual-risk discussion at consent surfaces the relevant items transparently — selected pharmacology has known side-effect patterns and selected pregnancy-related restrictions; selected procedural pathways have their own residual-risk profile around post-procedure pigmentation responses, prolonged redness, or selected unusual response patterns. The framework treats residual-risk as substantive content rather than as legal-defensive language.

Active acne management pricing depends on the calibrated pharmacology, the supporting visits, and any procedural adjuncts. Scar-resurfacing pricing is structured per-session per-modality. The dermatology consultation is priced at ₹1,999*; per-pathway pricing is calibrated case-by-case at the consultation rather than displayed as a website list. The Pricing FAQs covers the framework.

Selected oral pathways operate well across short pauses; selected pathways respond better to continuity. Where the patient anticipates a pause for travel, work-context, or pregnancy-planning the consultation discusses the trade-offs and adjusts. The framework treats patient-life-context as part of pathway calibration rather than against it.

Active management follow-up is typically four-to-six-week review windows during the early-active phase, transitioning to longer-interval review as the trajectory stabilises. Photographic comparison supports the conversation. The framework prioritises catching incomplete responders early and adjusting the calibration rather than waiting until the end of a fixed protocol to revise.

Scar-resurfacing follow-up is structured around the response window for the modality used — typically three months between sessions for fractional resurfacing, with longer-window response evaluation across six-to-twelve months. Multi-modality combination plans review at the cumulative review window rather than after each touch-point.

Selected continuity-of-care reviews where in-person examination is not necessary — particularly for stable adult-acne maintenance review and selected oral-pathway monitoring conversations — are appropriate for video format. Initial assessment, severity grading, and decisions that depend on hands-on examination are routed in-person. The Teleconsultation Policy in the policies section is the formal source.

Patient health information including any photographic record of acne severity and trajectory is held under the Patient Privacy and Records Policy framework as confidential, access-controlled material. Acne photography is particularly sensitive for many patients; access is limited to the dermatologist and trained clinical-team members involved in care. Patient images are not transferred to external marketing parties through the framework absent specific consent. For binding acne-pathway record mechanics the privacy policy document is the formal source.

Active flares during the management window are part of the trajectory in some cases and are handled through follow-up calibration rather than as a failure. Patients with significant flare or unusual response are encouraged to contact the clinic through the formal channel for active-pathway queries. The framework includes flare-management within the active care continuum.